Enochian Biosciences Inc Sample Contracts

SECURITIES PURCHASE AGREEMENT
Securities Purchase Agreement • June 16th, 2021 • Enochian Biosciences Inc • Pharmaceutical preparations • New York

This Securities Purchase Agreement (this “Agreement”) is dated as of June 14, 2021, between Enochian Biosciences Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).

Sample 1Sample 2Sample 3See All (1k)
AutoNDA by SimpleDocs
REGISTRATION RIGHTS AGREEMENT
Registration Rights Agreement • June 27th, 2023 • Enochian Biosciences Inc • Pharmaceutical preparations

THIS REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of June 20, 2023, is made by and between ENOCHIAN BIOSCIENCES INC., a Delaware corporation (the “Company”), and LINCOLN PARK CAPITAL FUND, LLC, an Illinois limited liability company (together with its permitted assigns, the “Buyer”). Capitalized terms used herein and not otherwise defined herein shall have the respective meanings set forth in the Purchase Agreement by and between the parties hereto, dated as of the date hereof (as amended, restated, supplemented or otherwise modified from time to time, the “Purchase Agreement”).

Sample 1Sample 2Sample 3See All (414)
PURCHASE AGREEMENT
Purchase Agreement • June 27th, 2023 • Enochian Biosciences Inc • Pharmaceutical preparations • Illinois

THIS PURCHASE AGREEMENT (the “Agreement”), dated as of June 20, 2023, is made by and between ENOCHIAN BIOSCIENCES INC., a Delaware corporation (the “Company”), and LINCOLN PARK CAPITAL FUND, LLC, an Illinois limited liability company (the “Investor”). Capitalized terms used herein and not otherwise defined herein are defined in Section 1 hereof.

Sample 1Sample 2Sample 3See All (171)
REGISTRATION RIGHTS AGREEMENT
Registration Rights Agreement • July 14th, 2020 • Enochian Biosciences Inc • Pharmaceutical preparations • Illinois

THIS REGISTRATION RIGHTS AGREEMENT (this “Agreement”), July 8, 2020, by and between ENOCHIAN BIOSCIENCES, INC., a Delaware corporation (the “Company”), and LINCOLN PARK CAPITAL FUND, LLC, an Illinois limited liability company (together with its permitted assigns, the “Investor”). Capitalized terms used herein and not otherwise defined herein shall have the respective meanings set forth in the Purchase Agreement by and between the parties hereto, dated as of the date hereof (as amended, restated, supplemented or otherwise modified from time to time, the “Purchase Agreement”).

Sample 1Sample 2Sample 3See All (50)
STRICTLY CONFIDENTIAL Enochian BioSciences, Inc. Century City Medical Plaza
Exclusive Agency Agreement • June 16th, 2021 • Enochian Biosciences Inc • Pharmaceutical preparations • New York
Sample 1Sample 2Sample 3See All (13)
PLACEMENT AGENCY AGREEMENT
Placement Agency Agreement • August 14th, 2014 • DanDrit Biotech USA, Inc. • Pharmaceutical preparations • New York
Sample 1Sample 2Sample 3See All (11)
COMMON STOCK PURCHASE AGREEMENT
Common Stock Purchase Agreement • August 12th, 2011 • Putnam Hills Corp. • Delaware

AGREEMENT entered into as of the 18thday of January, 2011, by and between Putnam Hills Corp., a Delaware corporation with an address at c/o Sunrise Securities, 641 Lexington Avenue, 25th Floor, New York, NY 10022 (the “Company”) and Nathan A. Low, an individual with an address c/o Sunrise Securities, 641 Lexington Avenue, 25th Floor, New York, NY 10022 (the “Purchaser”).

Sample 1Sample 2Sample 3See All (6)
COMMON STOCK PURCHASE WARRANT Renovaro inc.
Common Stock Purchase Warrant • June 21st, 2024 • Renovaro Inc. • Pharmaceutical preparations • Delaware

THIS COMMON STOCK PURCHASE WARRANT (this “Warrant”) certifies that, for value received, [●] (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time after the Issue Date (the “Initial Exercise Date”) and on or prior to the close of business on the Termination Date (as defined below) but not thereafter, to subscribe for and purchase from Renovaro Inc., a Delaware corporation (the “Company”), of up to [●] shares (subject to adjustment hereunder, the “Warrant Shares”) of the Company’s Common Stock, par value $0.0001 per share (“Common Stock”).

Sample 1Sample 2Sample 3See All (4)
FORM OF COMMON STOCK PURCHASE WARRANT enochian biosciences inc.
Warrant Agreement • August 7th, 2023 • Renovaro Biosciences Inc. • Pharmaceutical preparations • Delaware

THIS COMMON STOCK PURCHASE WARRANT (this “Warrant”) certifies that, for value received [●] (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time after the Issue Date (the “Initial Exercise Date”) and on or prior to the close of business on the Termination Date (as defined below) but not thereafter, to subscribe for and purchase from Enochian Biosciences Inc., a Delaware corporation (the “Company”), of up to [●] shares (subject to adjustment hereunder, the “Warrant Shares”) of the Company’s Common Stock, par value $0.0001 per share (“Common Stock”).

Sample 1Sample 2Sample 3See All (4)
SUBSCRIPTION AGREEMENT
Subscription Agreement • February 23rd, 2018 • DanDrit Biotech USA, Inc. • Pharmaceutical preparations • Delaware

This SUBSCRIPTION AGREEMENT (this “Subscription Agreement”) is made by and between DanDrit Biotech USA, Inc. a Delaware corporation (the “Company”), and the undersigned (“Subscriber”) as of the date this Subscription Agreement is accepted by the Company, as set forth on the Company’s signature page hereto.

Sample 1Sample 2Sample 3
MASTER SERVICES AGREEMENT
Master Services Agreement • February 14th, 2014 • DanDrit Biotech USA, Inc. • Blank checks • England

This Master Services Agreement (the “Agreement”) is made and entered into on 11th October, 2011, (the “Effective Date”), by and between DanDrit Biotech A/S, a Danish corporation, with offices at Høffdingsvej 34, 2500 Valby, Denmark (hereinafter referred to as “Client”) and Aptiv Solutions (UK) Ltd, together with its Affiliates, with offices at Hemel One, Boundary Way, Hemel Hempstead, Hertfordshire, HP2 (hereinafter referred to as “Aptiv Solutions”), both hereinafter referred as a “Party” or collectively as the “Parties”.

Sample 1Sample 2Sample 3
FORM OF SUBSCRIPTION AGREEMENT
Subscription Agreement • October 10th, 2023 • Renovaro Biosciences Inc. • Pharmaceutical preparations • Delaware

This SUBSCRIPTION AGREEMENT (this “Subscription Agreement”) is made by and between Renovaro BioSciences Inc., a Delaware corporation (the “Company”), and the other signatories listed on the signature pages hereto (each, a “Subscriber”, and collectively, the “Subscribers”) as of October __, 2023.

Sample 1Sample 2Sample 3
THIS WARRANT AND THE SHARES ISSUABLE UPON THE EXERCISE OF THIS WARRANT HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED. EXCEPT AS OTHERWISE SET FORTH HEREIN NEITHER THIS WARRANT NOR ANY OF SUCH SHARES MAY BE SOLD, TRANSFERRED OR...
Warrant Agreement • February 9th, 2018 • DanDrit Biotech USA, Inc. • Pharmaceutical preparations • Delaware

THIS Common Stock Purchase Warrant CERTIFIES THAT, for value received, ____________ or his registered assigns (“Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to 5:00 PM Eastern Standard Time on December 31, 2019 (the “Expiration Date”) but not thereafter, to subscribe for and purchase from DanDrit Biotech USA, Inc., a Delaware corporation with offices at Stumpedyssevej 17, 2970 Hørsholm, Denmark (the “Company”) an aggregate of up to 300,000 shares of common stock, par value $0.0001 per share, of the Company (the “Shares”), at an initial price per Share of $2.00, as adjusted in accordance with Section 2 below (the “Purchase Price”).

Sample 1Sample 2Sample 3
SELLER REGISTRATION RIGHTS AGREEMENT
Seller Registration Rights Agreement • February 14th, 2024 • Renovaro Inc. • Pharmaceutical preparations • Delaware

THIS SELLER REGISTRATION RIGHTS AGREEMENT (this “Agreement”) is entered into as of February 13, 2024 (the “Execution Date”), by and among Renovaro Biosciences Inc., a Delaware corporation (together with its successors, the “Purchaser”), and the undersigned parties listed as “Investors” on the signature page hereto (the “Investors” and each an “Investor”).

Sample 1Sample 2
Subscription Agreement
Subscription Agreement • July 3rd, 2014 • DanDrit Biotech USA, Inc. • Pharmaceutical preparations • New York

The undersigned (the “Investor”) hereby confirms and agrees with DanDrit Biotech USA, Inc., a Delaware corporation (the “Company”), as follows:

Sample 1Sample 2
SUBSCRIPTION AGREEMENT
Subscription Agreement • February 23rd, 2018 • DanDrit Biotech USA, Inc. • Pharmaceutical preparations • Delaware

This SUBSCRIPTION AGREEMENT (this “Subscription Agreement”) is made by and between DanDrit Biotech USA, Inc. a Delaware corporation (the “Company”), and the undersigned (“Subscriber”) as of the date this Subscription Agreement is accepted by the Company, as set forth on the Company’s signature page hereto.

Sample 1Sample 2
CONSULTING AGREEMENT
Consulting Agreement • May 15th, 2018 • Enochian Biosciences Inc • Pharmaceutical preparations • Florida

This CONSULTING AGREEMENT (this “Agreement”) is made and entered into as of February 16, 2018 (the “Effective Date”), by and among Dandrit Biotech USA, Inc. (the “Company”), its wholly owned subsidiary, Enochian Biopharma, Inc. (“Enochian) and Carl Sandler, an individual (the “Consultant”).

Sample 1Sample 2
BUSINESS LEASE AGREEMENT SUBLESSOR: Paseco ApS, Danish CVR No 31 36 36 08 LESSEE: Dandrit Biotech, A/S, Danish CVR No 26 02 73 22 PREMISES: Bredgade 75, 3rd floor, DK-1263 Copenhagen K
Business Lease Agreement • March 31st, 2014 • DanDrit Biotech USA, Inc. • Pharmaceutical preparations

The premises are to be used for offices and may not, without the written consent of the Sublessor, be used for any other purpose.

Sample 1Sample 2
CFO Service Agreement
Cfo Service Agreement • September 29th, 2017 • DanDrit Biotech USA, Inc. • Pharmaceutical preparations

DanDrit Biotech A/S CVR No 26 02 73 22 c/o Symbion Science Park Fruebjergvej 3 2100 Copenhagen Denmark (hereinafter referred to as the ”Company”)

Sample 1
SUBSCRIPTION AGREEMENT
Subscription Agreement • June 21st, 2024 • Renovaro Inc. • Pharmaceutical preparations • Delaware

This SUBSCRIPTION AGREEMENT (this “Subscription Agreement”) is made by and between Renovaro Inc., a Delaware corporation (the “Company”), and [●] (the “Subscriber”) as of June 14, 2024.

Sample 1
AGREEMENT AND PLAN OF SHARE EXCHANGE
Share Exchange Agreement • February 14th, 2014 • DanDrit Biotech USA, Inc. • Blank checks • Delaware

This AGREEMENT AND PLAN OF SHARE EXCHANGE (this “Agreement”) is entered into as of this 12th day of February, 2014 by and among Putnam Hills Corp., a Delaware corporation (“Putnam”), Dandrit BioTech A/S, a Danish company (“Dandrit”) and Niels Erik Nielsen (the “Shareholders’ Representative”), the representative of shareholders a majority of the issued and outstanding capital stock of Dandrit (collectively, the “Dandrit Consenting Shareholders” and together will all other holders of the outstanding capital stock of Dandrit, each a “Dandrit Shareholder”, and collectively, the “Dandrit Shareholders”). Each of the parties to this Agreement is individually referred to herein as a “Party” and collectively as the “Parties”.

Sample 1
SUBSCRIPTION AGREEMENT
Subscription Agreement • March 24th, 2021 • Enochian Biosciences Inc • Pharmaceutical preparations • Florida

This SUBSCRIPTION AGREEMENT (this “Subscription Agreement”) is made by and between Enochian BioSciences Inc., a Delaware corporation (the “Company”), and the other signatories listed on the signature pages hereto (each, a “Subscriber”, and collectively, the “Subscribers”) as of March ____, 2021.

Sample 1
AutoNDA by SimpleDocs
CFO SERVICE AGREEMENT between DanDrit Biotech A/S CVR No 26 02 73 22 c/o Symbion Science Park Fruebjergvej 3 (hereinafter referred to as the "Company") and Robert E. Wolfe PO Box 189 Randolph, VT 05060 (hereinafter referred to as the "CFO")
Cfo Service Agreement • June 23rd, 2014 • DanDrit Biotech USA, Inc. • Pharmaceutical preparations
Sample 1
EMPLOYMENT AGREEMENT
Employment Agreement • November 14th, 2024 • Renovaro Inc. • Pharmaceutical preparations • Delaware

This EMPLOYMENT AGREEMENT (this “Agreement”), dated as of October 14, 2024, by and between DAVID WEINSTEIN, residing at 23277 Water Circle, Boca Raton, Florida 33486 (the “Senior Executive”), and RENOVARO, INC., a Delaware corporation with its mailing address located at 2080 Century Park East, 906, Los Angeles, CA 90067 (the “Company”).

Sample 1
FORM OF STANDSTILL AND LOCK-UP AGREEMENT
Standstill and Lock-Up Agreement • January 17th, 2018 • DanDrit Biotech USA, Inc. • Pharmaceutical preparations

This Standstill and Lock-Up Agreement (this “Agreement”) is made and entered into as of [●], 2018 (the “Effective Date”), by and among DanDrit Biotech USA, Inc., a Delaware corporation (“Parent”), Weird Science, LLC, a California limited liability company (the “Majority Stockholder”) and RS Group ApS, a Danish limited company and a stockholder of Parent (“RS Group” and together with Majority Stockholder, the “Stockholders” and each, a “Stockholder”). Parent, Majority Stockholder and RS Group are each referred to as a “Party” or collectively as the “Parties.”

Sample 1
AMENDMENT NO. 1 TO CONVERTIBLE PROMISSORY NOTE
Convertible Promissory Note • February 9th, 2018 • DanDrit Biotech USA, Inc. • Pharmaceutical preparations

This Amendment No. 1 to Convertible Promissory Note (this “Amendment”), dated as of _________, 2017 (the “Effective Date”), is entered into by and between DanDrit Biotech USA, Inc., a Delaware corporation (the “Company”), and ___________ (the “Holder”).

Sample 1
DEBT INSTRUMENT was concluded on this day between Sune Olsen Holding ApS Jagtvej 169B, 3rd floor DK­-2100 Copenhagen Ø Danish CVR No 25372727 of the first part (hereinafter referred to as the “Creditor”) and Dandrit Biotech A/S Symbion Sciencepark,...
Debt Instrument • February 14th, 2014 • DanDrit Biotech USA, Inc. • Blank checks

Place: Copenhagen Ø Place: Copenhagen Ø Date: March 31, 2013 Date: March 31, 2013 As the Debtor: As the Creditor: /s/ Eric Leire, CEO, DanDrit Biotech A/S /s/ Sune Olsen, President, Sune Olsen Holding ApS

Sample 1
STATEMENT OF WORK AND LICENSE AGREEMENT for Influenza and Coronavirus Indications
Statement of Work and License Agreement • April 22nd, 2021 • Enochian Biosciences Inc • Pharmaceutical preparations • California

This Statement of Work and License Agreement for Influenza and Coronavirus Indications effective as of April 18, 2021 (the “Effective Date”), is made by and among G TECH BIO, LLC, a California limited liability company (“Licensor”), ENOCHIAN BIOSCIENCES, INC., a Delaware corporation (“Licensee”) and G HEALTH RESEARCH FOUNDATION, a not-for-profit entity organized under the laws of the state of California doing business as Seraph Research Institute (“SRI” and, together with Licensor, the “Research Parties;” and Licensee, SRI and Licensor, collectively the “Parties” and each, a “Party”).

Sample 1
EARLY ACCESS AGREEMENT
Early Access Agreement • February 14th, 2014 • DanDrit Biotech USA, Inc. • Blank checks

This exclusive Early Access Agreement (“Agreement”) is made and entered into the 20th day of December 2013 (“Effective Date”) by and between

Sample 1
FORM OF INVESTOR RIGHTS AGREEMENT
Investor Rights Agreement • January 17th, 2018 • DanDrit Biotech USA, Inc. • Pharmaceutical preparations

This Investor Rights Agreement (this “Agreement”) is made and entered into as of [●], 2018 (the “Effective Date”), by and among DanDrit Biotech USA, Inc., a Delaware corporation (“Parent”), Weird Science, LLC, a California limited liability company (“Majority Stockholder”) and RS Group ApS, a Danish limited company and a stockholder of Parent (“RS Group” and together with Majority Stockholder, the “Stockholders”). Parent and each Stockholder are each referred to as a “Party” or collectively as the “Parties.”

Sample 1
Contact: For Immediate Release
Collaboration Agreement • September 30th, 2014 • DanDrit Biotech USA, Inc. • Pharmaceutical preparations
Sample 1
AMENDMENT NO. 3 TO PROMISSORY NOTE
Promissory Note • February 23rd, 2023 • Enochian Biosciences Inc • Pharmaceutical preparations

This Amendment No. 3 to Promissory Note (this “Amendment”), dated as of December 30, 2022 (the “Effective Date”), is entered into by and between ENOCHIAN BIOSCIENCES, INC., a Delaware corporation (the “Company”), and PASECO APS (the “Holder”).

Sample 1
Contract
Cfo Contract • March 18th, 2015 • DanDrit Biotech USA, Inc. • Pharmaceutical preparations

Agreement between Dandrit Biotech A/S, Fruebjergvej 3, 2100 Kebenhavn 0, CVR 26027322 (Chairman of the board - Attorney at Law Niels Erik Nielsen) and Robert W Wolfe, Randolph, Vermont regarding the continuance and termination of the CFO Contract dated Feb. 10 2014.

Sample 1
SECOND AMENDMENT TO Stock Purchase Agreement
Stock Purchase Agreement • February 14th, 2024 • Renovaro Inc. • Pharmaceutical preparations

This Second Amendment (this “Amendment”) to the Stock Purchase Agreement, dated as of September 28, 2023 (the “Agreement”), by and among Renovaro Biosciences Inc., a Delaware corporation (“Buyer”), Gedi Cube Intl Ltd., a private limited company incorporated under the laws of England and Wales (“Company”), each of the shareholders of the Company signatory thereto (collectively, the “Sellers”) and Yalla Yalla Ltd., a private limited liability company registered and incorporated under the laws of Malta with company registration number C 103531, in its capacity as representative to the Sellers, is dated February 9, 2024. Capitalized terms used herein, which are not otherwise defined herein, shall have the meanings assigned to such terms in the Agreement.

Sample 1
SUBSCRIPTION AGREEMENT
Subscription Agreement • April 3rd, 2023 • Enochian Biosciences Inc • Pharmaceutical preparations • Delaware
Sample 1
Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!